State inspectors found that Resident #4 and Resident #6 had orders for Lorazepam, a controlled anti-anxiety medication, without the required 14-day stop dates. Federal rules mandate that PRN orders for psychotropic medications must be limited to no more than 14 days unless a physician documents specific rationale for extension.
The facility's Assistant Director of Nursing told inspectors she "did not think anything of the 14 day stop date" because she assumed hospice care providers would handle medication oversight. She admitted nurses had received no specific formal training on the 14-day requirement.
"I expected her nurses to pay attention to the stop date when the medication was ordered," the ADON said during interviews. She stated there was "no reason" why the two residents' Lorazepam orders lacked proper stop dates.
The ADON acknowledged confusion about which provider should ensure compliance. She told inspectors she "assumed it was hospice that ensured there was a 14 day stop date" but later said "it should be whichever nurse enters the order in the resident's EMR."
For Resident #6, the ADON could not explain why Lorazepam was prescribed, stating the medication "was not typically used for pain" and that she would need to follow up with investigators about its purpose.
Resident #4's case revealed additional oversight failures. The resident's physician order had not been updated to reflect a 90-day stop date recommended by the pharmacy consultant in 2024. The ADON said she "expected the resident's physician order to be updated and reflect the recommendation from the Pharmacy Consultant and the assigned doctor."
The facility's pharmacy consultant told inspectors he was "unsure if he had already identified the lack of a 14 day stop date" for both residents. He stated he would need to review his notes but could not access them during the interview. The consultant acknowledged that when he identifies PRN anti-anxiety or antipsychotic medications during reviews, he "generally would let the facility and doctor know through written notification."
When asked about potential consequences, the pharmacy consultant said residents "could receive the medication longer than he or she needed" without proper stop dates.
The facility's own policy, dated July 2025, explicitly states that "PRN orders for psychotropic medication, excluding antipsychotics, shall be limited to no more than 14 days, unless the attending physician or prescribing practitioner, believes it is appropriate to extend the order beyond the 14 days."
The policy requires medical records to include "documentation from the physician or prescriber for the rationale for the extended time" and "indicate a specific duration." For antipsychotic medications, the policy allows "no exception" to the 14-day limit.
The violations occurred despite the facility's stated intent to ensure residents "only receive psychotropic medication's when other non-pharmacological interventions are clinically contraindicated." The policy emphasizes that such medications should "only be used to treat the residence, Medical Center, and not used for discipline or staff convenience."
The ADON's admission that nurses lacked formal training on medication stop dates suggests systemic gaps in staff education. Her uncertainty about whether hospice providers had access to the facility's electronic medical record system highlighted coordination problems between care teams.
Federal regulations treat psychotropic medications as chemical restraints when used improperly. The 14-day limitation exists specifically to prevent residents from receiving mind-altering drugs longer than medically necessary.
The inspection findings revealed a facility where multiple staff members - from bedside nurses to the pharmacy consultant - failed to ensure basic medication safety protocols. The ADON's expectation that nurses would "pay attention" to stop dates proved insufficient without proper training and oversight systems.
Both residents affected by the violations remained at risk of receiving anti-anxiety medication beyond appropriate timeframes, with no clear accountability for ensuring compliance with federal safety requirements.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Avir At Lubbock from 2025-09-05 including all violations, facility responses, and corrective action plans.